Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1975 4
1976 3
1977 3
1978 2
1979 2
1980 3
1981 3
1982 1
1984 5
1985 5
1986 10
1987 4
1988 6
1989 9
1990 8
1991 6
1992 5
1993 5
1994 9
1995 2
1996 2
1997 6
1999 9
2000 4
2001 8
2002 9
2003 5
2004 9
2005 10
2006 4
2007 3
2008 7
2009 1
2010 2
2011 5
2012 2
2013 1
2014 1
2015 1
2016 2
2018 1
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Mass spectrometry.
Burlingame AL, Baillie TA, Russell DH. Burlingame AL, et al. Among authors: baillie ta. Anal Chem. 1992 Jun 15;64(12):467R-502R. doi: 10.1021/ac00036a025. Anal Chem. 1992. PMID: 1626707 Review. No abstract available.
Mass spectrometry.
Burlingame AL, Baillie TA, Derrick PJ. Burlingame AL, et al. Among authors: baillie ta. Anal Chem. 1986 Apr;58(5):165R-211R. doi: 10.1021/ac00296a015. Anal Chem. 1986. PMID: 3521386 Review. No abstract available.
Targeted Covalent Inhibitors for Drug Design.
Baillie TA. Baillie TA. Angew Chem Int Ed Engl. 2016 Oct 17;55(43):13408-13421. doi: 10.1002/anie.201601091. Epub 2016 Aug 19. Angew Chem Int Ed Engl. 2016. PMID: 27539547 Review.
The resurgence of covalent drugs.
Singh J, Petter RC, Baillie TA, Whitty A. Singh J, et al. Among authors: baillie ta. Nat Rev Drug Discov. 2011 Apr;10(4):307-17. doi: 10.1038/nrd3410. Nat Rev Drug Discov. 2011. PMID: 21455239 Review.
Drug metabolites in safety testing.
Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossman SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA. Baillie TA, et al. Toxicol Appl Pharmacol. 2002 Aug 1;182(3):188-96. doi: 10.1006/taap.2002.9440. Toxicol Appl Pharmacol. 2002. PMID: 12229863 Review.
Managing the challenge of chemically reactive metabolites in drug development.
Park BK, Boobis A, Clarke S, Goldring CE, Jones D, Kenna JG, Lambert C, Laverty HG, Naisbitt DJ, Nelson S, Nicoll-Griffith DA, Obach RS, Routledge P, Smith DA, Tweedie DJ, Vermeulen N, Williams DP, Wilson ID, Baillie TA. Park BK, et al. Among authors: baillie ta. Nat Rev Drug Discov. 2011 Apr;10(4):292-306. doi: 10.1038/nrd3408. Nat Rev Drug Discov. 2011. PMID: 21455238 Review.
Enzyme kinetics of cytochrome P450-mediated reactions.
Shou M, Lin Y, Lu P, Tang C, Mei Q, Cui D, Tang W, Ngui JS, Lin CC, Singh R, Wong BK, Yergey JA, Lin JH, Pearson PG, Baillie TA, Rodrigues AD, Rushmore TH. Shou M, et al. Among authors: baillie ta. Curr Drug Metab. 2001 Mar;2(1):17-36. doi: 10.2174/1389200013338784. Curr Drug Metab. 2001. PMID: 11465149 Review.
184 results